Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro):
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2016
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Aus: Annals of Oncology 25.1 (2014): S. 81-89. <http://annonc.oxfordjournals.org/content/25/1/81.abstract> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. |
| Beschreibung: | 1 Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043787628 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160921s2016 gw |||| o||u| ||||||eng d | ||
| 015 | |a 16,O10 |2 dnb | ||
| 016 | 7 | |a 1113290323 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-73842 |2 urn | |
| 035 | |a (OCoLC)959571291 | ||
| 035 | |a (DE-599)DNB1113290323 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Minckwitz, G. von |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |c G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2016 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Aus: Annals of Oncology 25.1 (2014): S. 81-89. <http://annonc.oxfordjournals.org/content/25/1/81.abstract> | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 500 | |a This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 653 | |a capecitabine | ||
| 653 | |a trastuzumab | ||
| 653 | |a neoadjuvant chemotherapy | ||
| 653 | |a disease-free survival | ||
| 653 | |a overall survival | ||
| 700 | 1 | |a Rezai, M. |e Verfasser |4 aut | |
| 700 | 1 | |a Fasching, Peter A. |e Verfasser |4 aut | |
| 700 | 1 | |a Huober, J. |e Verfasser |4 aut | |
| 700 | 1 | |a Tesch, H. |e Verfasser |4 aut | |
| 700 | 1 | |a Bauerfeind, I. |e Verfasser |4 aut | |
| 700 | 1 | |a Hilfrich, J. |e Verfasser |4 aut | |
| 700 | 1 | |a Eidtmann, H. |e Verfasser |4 aut | |
| 700 | 1 | |a Gerber, B. |e Verfasser |4 aut | |
| 700 | 1 | |a Hanusch, C. |e Verfasser |4 aut | |
| 700 | 1 | |a Blohmer, J. U. |e Verfasser |4 aut | |
| 700 | 1 | |a Costa, S. D. |e Verfasser |4 aut | |
| 700 | 1 | |a Jackisch, C. |e Verfasser |4 aut | |
| 700 | 1 | |a Paepke, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Schneeweiss, A. |e Verfasser |4 aut | |
| 700 | 1 | |a Kümmel, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Denkert, C. |e Verfasser |4 aut | |
| 700 | 1 | |a Mehta, K. |e Verfasser |4 aut | |
| 700 | 1 | |a Loibl, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Untch, M. |e Verfasser |4 aut | |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-73842 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1113290323/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/7384 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029198684 | ||
Datensatz im Suchindex
| _version_ | 1804176624597336064 |
|---|---|
| any_adam_object | |
| author | Minckwitz, G. von Rezai, M. Fasching, Peter A. Huober, J. Tesch, H. Bauerfeind, I. Hilfrich, J. Eidtmann, H. Gerber, B. Hanusch, C. Blohmer, J. U. Costa, S. D. Jackisch, C. Paepke, S. Schneeweiss, A. Kümmel, S. Denkert, C. Mehta, K. Loibl, S. Untch, M. |
| author_facet | Minckwitz, G. von Rezai, M. Fasching, Peter A. Huober, J. Tesch, H. Bauerfeind, I. Hilfrich, J. Eidtmann, H. Gerber, B. Hanusch, C. Blohmer, J. U. Costa, S. D. Jackisch, C. Paepke, S. Schneeweiss, A. Kümmel, S. Denkert, C. Mehta, K. Loibl, S. Untch, M. |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Minckwitz, G. von |
| author_variant | g v m gv gvm m r mr p a f pa paf j h jh h t ht i b ib j h jh h e he b g bg c h ch j u b ju jub s d c sd sdc c j cj s p sp a s as s k sk c d cd k m km s l sl m u mu |
| building | Verbundindex |
| bvnumber | BV043787628 |
| collection | ebook |
| ctrlnum | (OCoLC)959571291 (DE-599)DNB1113290323 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03155nmm a2200697zc 4500</leader><controlfield tag="001">BV043787628</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160921s2016 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">16,O10</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1113290323</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-73842</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)959571291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1113290323</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Minckwitz, G. von</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)</subfield><subfield code="c">G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Aus: Annals of Oncology 25.1 (2014): S. 81-89. <http://annonc.oxfordjournals.org/content/25/1/81.abstract></subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">capecitabine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trastuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neoadjuvant chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease-free survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">overall survival</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rezai, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fasching, Peter A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huober, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesch, H.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bauerfeind, I.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hilfrich, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eidtmann, H.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerber, B.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hanusch, C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blohmer, J. U.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Costa, S. D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jackisch, C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paepke, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schneeweiss, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kümmel, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Denkert, C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehta, K.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Loibl, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Untch, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-73842</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1113290323/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/7384</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029198684</subfield></datafield></record></collection> |
| id | DE-604.BV043787628 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:35:09Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029198684 |
| oclc_num | 959571291 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Minckwitz, G. von Verfasser aut Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2016 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aus: Annals of Oncology 25.1 (2014): S. 81-89. <http://annonc.oxfordjournals.org/content/25/1/81.abstract> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. Langzeitarchivierung gewährleistet, LZA capecitabine trastuzumab neoadjuvant chemotherapy disease-free survival overall survival Rezai, M. Verfasser aut Fasching, Peter A. Verfasser aut Huober, J. Verfasser aut Tesch, H. Verfasser aut Bauerfeind, I. Verfasser aut Hilfrich, J. Verfasser aut Eidtmann, H. Verfasser aut Gerber, B. Verfasser aut Hanusch, C. Verfasser aut Blohmer, J. U. Verfasser aut Costa, S. D. Verfasser aut Jackisch, C. Verfasser aut Paepke, S. Verfasser aut Schneeweiss, A. Verfasser aut Kümmel, S. Verfasser aut Denkert, C. Verfasser aut Mehta, K. Verfasser aut Loibl, S. Verfasser aut Untch, M. Verfasser aut https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-73842 Resolving-System kostenfrei Volltext http://d-nb.info/1113290323/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/7384 Verlag kostenfrei Volltext |
| spellingShingle | Minckwitz, G. von Rezai, M. Fasching, Peter A. Huober, J. Tesch, H. Bauerfeind, I. Hilfrich, J. Eidtmann, H. Gerber, B. Hanusch, C. Blohmer, J. U. Costa, S. D. Jackisch, C. Paepke, S. Schneeweiss, A. Kümmel, S. Denkert, C. Mehta, K. Loibl, S. Untch, M. Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |
| title | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |
| title_auth | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |
| title_exact_search | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |
| title_full | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch |
| title_fullStr | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch |
| title_full_unstemmed | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) G. von Minckwitz ; M. Rezai ; Peter A. Fasching ; J. Huober ; H. Tesch ; I. Bauerfeind ; J. Hilfrich ; H. Eidtmann ; B. Gerber ; C. Hanusch ; J. U. Blohmer ; S. D. Costa ; C. Jackisch ; S. Paepke ; A. Schneeweiss ; S. Kümmel ; C. Denkert ; K. Mehta ; S. Loibl ; M. Untch |
| title_short | Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro) |
| title_sort | survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline taxane based chemotherapy for primary breast cancer gbg 40 geparquattro |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-73842 http://d-nb.info/1113290323/34 https://open.fau.de/handle/openfau/7384 |
| work_keys_str_mv | AT minckwitzgvon survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT rezaim survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT faschingpetera survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT huoberj survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT teschh survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT bauerfeindi survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT hilfrichj survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT eidtmannh survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT gerberb survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT hanuschc survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT blohmerju survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT costasd survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT jackischc survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT paepkes survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT schneeweissa survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT kummels survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT denkertc survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT mehtak survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT loibls survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro AT untchm survivalafteraddingcapecitabineandtrastuzumabtoneoadjuvantanthracyclinetaxanebasedchemotherapyforprimarybreastcancergbg40geparquattro |